{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:35Z","timestamp":1786119275838,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"DOI":"10.1097\/qai.0b013e31815e722b","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T10:35:29Z","timestamp":1236249329000},"page":"422-428","source":"Crossref","is-referenced-by-count":50,"title":["Characteristics and Outcome of AIDS-Related Hodgkin Lymphoma Before and After the Introduction of Highly Active Antiretroviral Therapy"],"prefix":"10.1097","volume":"47","author":[{"given":"Juan","family":"Berenguer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Miralles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mahillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Pintado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"La Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Torre-Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rodr\u00edguez-Arrondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Antonia","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galo","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Boix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7326\/0003-4819-117-4-309","article-title":"Increased incidence of Hodgkin disease in homosexual men with HIV infection.","volume":"117","author":"Hessol","year":"1992","journal-title":"Ann Intern Med"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1200\/JCO.1995.13.10.2540","article-title":"Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men.","volume":"13","author":"Lyter","year":"1995","journal-title":"J Clin Oncol"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/bjc.1998.610","article-title":"Risk of cancer other than Kaposis sarcoma and non-Hodgkins lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study.","volume":"78","author":"Franceschi","year":"1998","journal-title":"Br J Cancer"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0889-8588(18)30446-5","article-title":"Hodgkins disease and AIDS. Twenty-three new cases and a review of the literature.","volume":"5","author":"Ames","year":"1991","journal-title":"Hematol Oncol Clin North Am"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1002\/1097-0142(20011201)92:11<2739::AID-CNCR10121>3.0.CO;2-E","article-title":"Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.","volume":"92","author":"Re","year":"2001","journal-title":"Cancer"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/00000478-199612000-00012","article-title":"Pathological, immunological, and molecular features of Hodgkins disease associated with HIV infection. Comparison with ordinary Hodgkins disease.","volume":"20","author":"Bellas","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0889-8588(03)00038-8","article-title":"Non-AIDS-defining cancer in HIV-infected people.","volume":"17","author":"Cooley","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0959-8049(01)00105-8","article-title":"Pathogenetic and histogenetic features of HIV-associated Hodgkins disease.","volume":"37","author":"Dolcetti","year":"2001","journal-title":"Eur J Cancer"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0959-8049(01)00123-X","article-title":"Epstein-Barr virus associated lymphoproliferations in the AIDS setting.","volume":"37","author":"Ambinder","year":"2001","journal-title":"Eur J Cancer"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-108-5-744","article-title":"Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986).","volume":"108","author":"Knowles","year":"1988","journal-title":"Ann Intern Med"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1097-0142(19880601)61:11<2325::AID-CNCR2820611130>3.0.CO;2-0","article-title":"AIDS-related lymphoid neoplasia. The Memorial Hospital experience.","volume":"61","author":"Lowenthal","year":"1988","journal-title":"Cancer"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/1097-0142(19900515)65:10<2248::AID-CNCR2820651015>3.0.CO;2-W","article-title":"Hodgkins disease in patients with antibodies to human immunodeficiency virus. A study of 22 patients.","volume":"65","author":"Serrano","year":"1990","journal-title":"Cancer"},{"issue":"Suppl 4","key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/annonc\/3.suppl_4.S69","article-title":"Hodgkins disease in 92 patients with HIV infection: the Italian experience. GICAT (Italian Cooperative Group on AIDS and Tumors).","volume":"3","author":"Tirelli","year":"1992","journal-title":"Ann Oncol"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.annonc.a058617","article-title":"Hodgkins disease during HIV1 infection: the French registry experience. French Registry of HIV-Associated Tumors.","volume":"4","author":"Andrieu","year":"1993","journal-title":"Ann Oncol"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/1097-0142(19940501)73:9<2400::AID-CNCR2820730925>3.0.CO;2-C","article-title":"Hodgkins disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.","volume":"73","author":"Rubio","year":"1994","journal-title":"Cancer"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/1097-0142(19910315)67:6<1614::AID-CNCR2820670624>3.0.CO;2-#","article-title":"Human immunodeficiency virus-associated Hodgkins disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells.","volume":"67","author":"Ree","year":"1991","journal-title":"Cancer"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/10428199509054433","article-title":"Human immunodeficiency virus associated Hodgkins disease: report of 45 cases from the French Registry of HIV-Associated Tumors.","volume":"16","author":"Levy","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.jncimonographs.a024171","article-title":"Hodgkins disease in the setting of human immunodeficiency virus infection.","volume":"23","author":"Levine","year":"1998","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/14737140.4.3.401","article-title":"Current treatment strategies for patients with Hodgkins lymphoma and HIV infection.","volume":"4","author":"Hartmann","year":"2004","journal-title":"Expert Rev Anticancer Ther"},{"key":"R20-3-20210131","first-page":"1","article-title":"1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/1097-0142(19940115)73:2<437::AID-CNCR2820730232>3.0.CO;2-2","article-title":"Combined antineoplastic and antiretroviral therapy for patients with Hodgkins disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT).","volume":"73","author":"Errante","year":"1994","journal-title":"Cancer"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.1995.13.7.1758","article-title":"Hodgkins disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.","volume":"13","author":"Tirelli","year":"1995","journal-title":"J Clin Oncol"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00042560-200008150-00009","article-title":"Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin disease: a prospective, multi-institutional AIDS Clinical Trials Group study (ACTG 149).","volume":"24","author":"Levine","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/00002030-200209270-00020","article-title":"Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkins disease.","volume":"16","author":"Ribera","year":"2002","journal-title":"AIDS"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2004.04934.x","article-title":"Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkins disease.","volume":"125","author":"Hoffmann","year":"2004","journal-title":"Br J Haematol"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002030-200301030-00011","article-title":"Improved survival in HIV-related Hodgkins lymphoma since the introduction of highly active antiretroviral therapy.","volume":"17","author":"Gerard","year":"2003","journal-title":"AIDS"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkins lymphomas. NCI Sponsored International Working Group.","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood.V98.12.3406","article-title":"Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.","volume":"98","author":"Kirk","year":"2001","journal-title":"Blood"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002.","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"R33-3-20210131","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R34-3-20210131","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1008338915945","article-title":"Hodgkins disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.","volume":"10","author":"Errante","year":"1999","journal-title":"Ann Oncol"},{"key":"R35-3-20210131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B","article-title":"Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.","volume":"91","author":"Vaccher","year":"2001","journal-title":"Cancer"},{"key":"R36-3-20210131","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2004-08-3300","article-title":"Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.","volume":"105","author":"Spina","year":"2005","journal-title":"Blood"},{"key":"R37-3-20210131","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2141.2001.02656.x","article-title":"Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkins lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone.","volume":"112","author":"Navarro","year":"2001","journal-title":"Br J Haematol"},{"key":"R38-3-20210131","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/aid.2005.21.214","article-title":"Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas.","volume":"21","author":"Lascaux","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R39-3-20210131","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/00002030-200307040-00013","article-title":"Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.","volume":"17","author":"Hoffmann","year":"2003","journal-title":"AIDS"},{"key":"R40-3-20210131","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00002030-199904160-00018","article-title":"HIV-associated non-Hodgkins lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy.","volume":"13","author":"Evison","year":"1999","journal-title":"AIDS"},{"key":"R41-3-20210131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/QAI.0b013e31802bb5d0","article-title":"Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors.","volume":"44","author":"Miralles","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R42-3-20210131","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","article-title":"Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.","volume":"100","author":"Spina","year":"2002","journal-title":"Blood"},{"key":"R43-3-20210131","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00002030-200107270-00006","article-title":"Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults.","volume":"15","author":"Bartlett","year":"2001","journal-title":"AIDS"},{"key":"R44-3-20210131","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/01.aids.0000247578.08449.ff","article-title":"An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults.","volume":"20","author":"Bartlett","year":"2006","journal-title":"AIDS"},{"key":"R45-3-20210131","doi-asserted-by":"crossref","first-page":"9198","DOI":"10.1200\/JCO.2005.02.907","article-title":"ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkins lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.","volume":"23","author":"Gobbi","year":"2005","journal-title":"J Clin Oncol"},{"key":"R46-3-20210131","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1200\/JCO.2005.03.2151","article-title":"Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkins lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).","volume":"23","author":"Johnson","year":"2005","journal-title":"J Clin Oncol"},{"key":"R47-3-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3324\/haematol.10479","article-title":"Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkins lymphoma.","volume":"92","author":"Xicoy","year":"2007","journal-title":"Haematologica"},{"key":"R48-3-20210131","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0140-6736(85)91736-2","article-title":"Review of British National Lymphoma Investigation studies of Hodgkins disease and development of prognostic index.","volume":"1","author":"Haybittle","year":"1985","journal-title":"Lancet"},{"key":"R49-3-20210131","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus involved-field radiation in early-stage Hodgkins disease.","volume":"357","author":"Ferme","year":"2007","journal-title":"N Engl J Med"},{"key":"R50-3-20210131","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkins disease. International Prognostic Factors Project on Advanced Hodgkins Disease.","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"R51-3-20210131","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdg152","article-title":"High international prognostic score predicts a worse outcome for patients with Hodgkins disease and HIV infection: results of a prospective study with Stanford V regimen.","volume":"14","author":"Spina","year":"2003","journal-title":"Ann Oncol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-200807000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:53:11Z","timestamp":1786038791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200804010-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31815e722b","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4,1]]}}}